Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study - PubMed (original) (raw)
Affiliations
- PMID: 7686224
Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study
J V Giorgi et al. J Acquir Immune Defic Syndr (1988). 1993 Aug.
Abstract
A cohort of 98 HIV-infected initially AIDS-free homosexual men from the Multicenter AIDS Cohort Study (MACS) was followed for 6 years to investigate whether CD8+ cell subsets have prognostic value for progression to AIDS. In the present study, four subsets of CD8+ T cells that previously have been shown to be selectively elevated in HIV-infected asymptomatic persons, specifically the CD8+ T cell subsets that were CD38+, HLA-DR+, CD57+ and L-selectin negative (Leu8-), were measured. Forty-nine of the 98 developed AIDS. Prognostic value of these CD8+ cell subsets was evaluated using the proportional hazards model. Levels of both CD38+ CD8+ and Leu8- CD8+ cells individually had prognostic value for progression to AIDS. In contrast, CD57+ CD8+ and HLA-DR+ CD8+ cell subsets levels did not have prognostic value. After adjustment for level of CD4+ T cells, however, only the elevation in the CD38+ CD8+ cell subset had additional prognostic value. These results suggest that the level of CD38+ CD8+ cells could be used together with the CD4+ T cell level to more accurately predict progression to AIDS among HIV-infected men. These results provide further support for the observation that dramatic and progressive activation of CD8+ T cells in HIV infection occurs. The power of elevated levels of the CD38+ CD8+ subset to predict poor prognosis in this cohort suggests these CD8+ T cells reflect an immune stimulation that is ultimately unable to control disease progression.
Similar articles
- Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection.
Prince HE, Jensen ER. Prince HE, et al. J Acquir Immune Defic Syndr (1988). 1991;4(12):1227-32. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1719188 - CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens.
Echaniz P, Arrizabalaga J, Iribarren JA, Cuadrado E. Echaniz P, et al. Cell Immunol. 1993 Aug;150(1):72-80. doi: 10.1006/cimm.1993.1179. Cell Immunol. 1993. PMID: 7688270 - A role for CD8+ T lymphocytes in the pathogenesis of AIDS.
Aranda-Anzaldo A. Aranda-Anzaldo A. Res Immunol. 1991 Sep;142(7):541-50. doi: 10.1016/0923-2494(91)90099-5. Res Immunol. 1991. PMID: 1687487 Free PMC article. Review. - The role of CD38 in HIV infection.
Lu L, Wang J, Yang Q, Xie X, Huang Y. Lu L, et al. AIDS Res Ther. 2021 Apr 5;18(1):11. doi: 10.1186/s12981-021-00330-6. AIDS Res Ther. 2021. PMID: 33820568 Free PMC article. Review.
Cited by
- Multiparameter Flow Cytometry Monitoring of T Cell Responses.
Maecker HT. Maecker HT. Methods Mol Biol. 2024;2807:325-342. doi: 10.1007/978-1-0716-3862-0_22. Methods Mol Biol. 2024. PMID: 38743238 - Active Tuberculosis Is Associated with Depletion of HIV-Specific CD4 and CD8 T Cells in People with HIV.
Khayumbi J, Sasser LE, McLaughlin TA, Muchiri B, Ongalo J, Tonui J, Ouma SG, Campbell A, Odhiambo FH, Kiprotich C, Gandhi NR, Day CL. Khayumbi J, et al. AIDS Res Hum Retroviruses. 2024 Jul;40(7):417-427. doi: 10.1089/AID.2023.0088. Epub 2024 Mar 14. AIDS Res Hum Retroviruses. 2024. PMID: 38366732 - CD38: an ecto-enzyme with functional diversity in T cells.
Ghosh A, Khanam A, Ray K, Mathur P, Subramanian A, Poonia B, Kottilil S. Ghosh A, et al. Front Immunol. 2023 Apr 27;14:1146791. doi: 10.3389/fimmu.2023.1146791. eCollection 2023. Front Immunol. 2023. PMID: 37180151 Free PMC article. - Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study.
Kroidl I, Ahmed MIM, Horn S, Polyak C, Esber A, Parikh A, Eller LA, Kibuuka H, Semwogerere M, Mwesigwa B, Naluyima P, Kasumba JM, Maswai J, Owuoth J, Sing'oei V, Rono E, Loose R, Hoelscher M, Ake J, Geldmacher C; AFRICOS Study Group. Kroidl I, et al. EClinicalMedicine. 2022 Jul 13;49:101470. doi: 10.1016/j.eclinm.2022.101470. eCollection 2022 Jul. EClinicalMedicine. 2022. PMID: 35873194 Free PMC article. - Detecting Sources of Immune Activation and Viral Rebound in HIV Infection.
Wietgrefe SW, Duan L, Anderson J, Marqués G, Sanders M, Cummins NW, Badley AD, Dobrowolski C, Karn J, Pagliuzza A, Chomont N, Sannier G, Dubé M, Kaufmann DE, Zuck P, Wu G, Howell BJ, Reilly C, Herschhorn A, Schacker TW, Haase AT. Wietgrefe SW, et al. J Virol. 2022 Aug 10;96(15):e0088522. doi: 10.1128/jvi.00885-22. Epub 2022 Jul 20. J Virol. 2022. PMID: 35856674 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous